Shanghai No.1 Pharmacy Co., Ltd.
Shanghai Stock ExchangeTotal Valuation
Shanghai No.1 Pharmacy Co., Ltd. carries a market capitalization of 2.18B, placing it among publicly traded companies globally. Its enterprise value stands at 2.66B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.18B |
| Enterprise Value | 2.66B |
Share Statistics
Shanghai No.1 Pharmacy Co., Ltd. currently has 223.09M shares outstanding.
| Shares Outstanding | 223.09M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Shanghai No.1 Pharmacy Co., Ltd. trades at a trailing price-to-earnings ratio of 60.03. The price-to-sales ratio is 1.41, and the price-to-book ratio stands at 3.69.
| PE Ratio | 60.03 |
| PS Ratio | 1.41 |
| PB Ratio | 3.69 |
| P/TBV Ratio | 2.64 |
| P/FCF Ratio | 144.80 |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 1.32 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 111.85 |
Financial Position
Shanghai No.1 Pharmacy Co., Ltd. maintains a current ratio of 1.59, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 18.19, indicating elevated leverage, while an interest coverage ratio of -0.57 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.59 |
| Quick Ratio | 0.54 |
| Debt / Equity | 18.19 |
| Debt / EBITDA | -64.33 |
| Interest Coverage | -0.57 |
Financial Efficiency
Shanghai No.1 Pharmacy Co., Ltd. posts a return on equity of 6.09 and a return on invested capital of -0.18.
| Return on Equity (ROE) | 6.09 |
| Return on Assets (ROA) | 2.40 |
| Return on Invested Capital (ROIC) | -0.18 |
| Return on Capital Employed (ROCE) | 4.96 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.44 |
Taxes
Over the trailing twelve months, Shanghai No.1 Pharmacy Co., Ltd. has paid 15.20M in income taxes, reflecting an effective tax rate of 23.97.
| Income Tax | 15.20M |
| Effective Tax Rate | 23.97 |
Stock Price Statistics
Shanghai No.1 Pharmacy Co., Ltd.'s stock has declined approximately -23.04657% over the past 52 weeks. The 50-day moving average sits at 10.79, while the 200-day moving average is 12.55.
| Beta (5Y) | N/A |
| 52-Week Price Change | -23.04657% |
| 50-Day Moving Average | 10.79 |
| 200-Day Moving Average | 12.55 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Shanghai No.1 Pharmacy Co., Ltd. generated 2.02B in revenue and converted that into 47.30M in net income, yielding earnings per share of 0.22. EBITDA reached -3.15M, while operating income came in at -3.15M.
| Revenue | 2.02B |
| Gross Profit | 333.50M |
| Operating Income | -3.15M |
| Pretax Income | 63.42M |
| Net Income | 47.30M |
| EBITDA | -3.15M |
| EBIT | -3.15M |
| Earnings Per Share (EPS) | 0.22 |
Balance Sheet
Shanghai No.1 Pharmacy Co., Ltd. holds 390.47M in cash and equivalents against 202.80M in total debt, resulting in a net debt position of -321.07M. Total book value stands at 770.30M, with working capital of 427.32M providing operational flexibility.
| Cash & Cash Equivalents | 390.47M |
| Total Debt | 202.80M |
| Net Debt | -321.07M |
| Equity (Book Value) | 770.30M |
| Book Value Per Share | 3.45 |
| Working Capital | 427.32M |
Cash Flow
After subtracting -19.61M in capital expenditures, free cash flow totaled -19.61M - equivalent to -0.09 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -19.61M |
| Free Cash Flow | -19.61M |
| FCF Per Share | -0.09 |
Margins
Shanghai No.1 Pharmacy Co., Ltd. operates with a gross margin of 16.52, reflecting its pricing power and cost economics. The operating margin of -0.16 and net profit margin of 2.34 provide insight into operational efficiency.
| Gross Margin | 16.52 |
| Operating Margin | -0.16 |
| Pretax Margin | 3.14 |
| Profit Margin | 2.34 |
| EBITDA Margin | -0.16 |
Dividends & Yields
The company's payout ratio of 3.16 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.01 |
| Dividend Yield | N/A |
| Payout Ratio | 3.16 |
| Shareholder Yield | 4.26 |
| FCF Yield | 0.69 |
Stock Splits
Shanghai No.1 Pharmacy Co., Ltd.'s most recent stock split took place on July 15, 2011 with a 5:7 split ratio.
| Last Split Date | 7/15/2011 |
| Split Ratio | 5:7 |
Scores
Shanghai No.1 Pharmacy Co., Ltd. posts an Altman Z-Score of 3.57, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.57 |